Apelin-13 Pretreatment Promotes the Cardioprotective Effect of Mesenchymal Stem Cells against Myocardial Infarction by Improving Their Survival
Although mesenchymal stem cell- (MSC-) based therapy has shown promising results for myocardial infarction (MI), low cell survival heavily limits its beneficial effects. Apelin plays an essential regulatory role in cell proliferation. This study was aimed at determining whether Apelin-13 pretreatmen...
Saved in:
Main Authors: | Guona Chen, Xiaoting Liang, Qian Han, Cong Mai, Linli Shi, Zhuang Shao, Yimei Hong, Fang Lin, Mimi Li, Bei Hu, Xin Li, Yuelin Zhang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Stem Cells International |
Online Access: | http://dx.doi.org/10.1155/2022/3742678 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The Cardioprotective Actions of Hydrogen Sulfide in Acute Myocardial Infarction and Heart Failure
by: David J. Polhemus, et al.
Published: (2014-01-01) -
Captopril Pretreatment Produces an Additive Cardioprotection to Isoflurane Preconditioning in Attenuating Myocardial Ischemia Reperfusion Injury in Rabbits and in Humans
by: Yi Tian, et al.
Published: (2015-01-01) -
Exosomes Derived from Apelin-Pretreated Mesenchymal Stem Cells Ameliorate Sepsis-Induced Myocardial Dysfunction by Alleviating Cardiomyocyte Pyroptosis via Delivery of miR-34a-5p
by: Li T, et al.
Published: (2025-01-01) -
Prognostic Value of Combining Apelin-12 and Estimated Glomerular Filtration Rate in Patients with ST-Segment Elevation Myocardial Infarction
by: Yue Liu, et al.
Published: (2022-01-01) -
Correlation between Apelin and Some Angiogenic Factors in the Pathogenesis of Preeclampsia: Apelin-13 as Novel Drug for Treating Preeclampsia and Its Physiological Effects on Placenta
by: Reham Z. Hamza, et al.
Published: (2021-01-01)